현재 위치 : HOME > 리포트 > 생명 공학 
 The global biophotonics market is anticipated to contribute $ 59 . 9 billion by 2022 growing at a CAGR of 11 . 6 % during 2016 - 2022 . The biophotonics market is segregated on the basis of end use including medical therapeutics , test components , medical diagnostics and non - medical end use . In 2015 , medical diagnostics segment holds the largest market share in the end use segment owing to its increasing adoption rate by numerous end - users which include instrument manufacturers , healthcare providers , research laboratories and medical institutes . However , the non - medical end use is anticipated to be the fastest growing segment due to its environmental screening and monitoring capabilities . 
 The improvement in the studies related to pathogen exposures in agricultural food items , continuous blood monitoring and inhibition of unauthorized data visualization is anticipated to significantly influence the biophotonics market for numerous non - medical applications . Furthermore , biophotonics finds its application in the study of working of molecular mechanisms , proteins , DNA and other important molecules . The global biophotonics market can further be bifurcated on the basis of application including surface imaging , see - through imaging , microscopy , endoscopy , light therapy , spectromolecular biosensors and others . 
 In 2015 , see - through imaging application segment held the largest market share owing to rising demand for radical non - invasive surgical procedures in numerous medical fields such as neurology , oncology , cardiology and brain imaging . However , surface imaging segment is expected to witness the highest CAGR during the forecast period .